Medifirst Solutions, Inc. (MFST) Return on Investment ROI from the third quarter of 2019 to third quarter of 2018 and for the year 2019, average high and low, overall ranking from Sep 30 2019 to Sep 30 2018 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Medifirst Solutions, Inc.  (MFST)


Medifirst Solutions,'s ROI from its third quarter of 2019 to the third quarter of 2018 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Medifirst Solutions,'s ROI in the third quarter of 2019?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Medifirst Solutions, Inc.'s return on investment (ROI) in its third quarter of 2019

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter
Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -1 -2 -2 -1 -1
Return On Investment (TTM) - - - - -
MFST's Overall Ranking # # # # #
Seq. Investment Change TTM - - - - -
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -2 -1 -2 -1 -1

MFST Company Profile >> Back to MFST Roi Comparisons >> See Annual MFST Return On Investment



Return On Investment MFST's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Medifirst Solutions,'s III. Quarter Investments $ -1 Millions MFST's Balance sheet
Medifirst Solutions,'s III. Quarter Income $ -1 Millions Quarterly MFST's Income Statement
MFST's Income by Division See MFST's Income by Division


MFST Annual Return On Investment (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016		 (Dec 31 2015)
2015		 (Dec 31 2014)
2014
Total Investments in Millions -1 -1 -1 -1 0
Y / Y Investment Growth - - - - -
Net Income in Millions -1 -2 -1 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment - - - - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
MFST's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for MFST's Competitors
Subscribers only: Roi for Medifirst Solutions,'s Suppliers
Subscribers only: Return On Investment for MFST's Customers

Other Ratios
MFST's Roa MFST's Inventory Turnover Ratio MFST's Growth Rates MFST's Dividend Statistics
MFST's Profitability Ratios MFST's Asset Turnover Ratio MFST's Dividend Growth
MFST's Roe MFST's Valuation Ratios MFST's Financial Strength Ratios MFST's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2019, within Healthcare Sector ROI
Tenax Therapeutics Inc   239.41 %
Aveo Pharmaceuticals Inc   180.27 %
Semler Scientific inc   177.60 %
89bio Inc   164.54 %
Jounce Therapeutics inc   154.69 %
Orgenesis Inc   70.97 %
Innoviva Inc   64.63 %
Oxford Immunotec Global Plc  63.62 %
Palatin Technologies Inc   63.14 %
Owc Pharmaceutical Research Corp.  62.12 %
Molecular Templates Inc   60.99 %
Lexicon Pharmaceuticals Inc   60.47 %
Zynex inc   59.55 %
Iveric Bio Inc   58.44 %
Viskase Holdings inc   54.57 %
Arena Pharmaceuticals Inc   50.22 %
Nrc Health  47.96 %
Castle Biosciences Inc   42.65 %
Remedent Inc   42.49 %
Exelixis Inc   41.45 %
Ligand Pharmaceuticals Incorporated  38.90 %
Oramed Pharmaceuticals Inc  37.93 %
Vanda Pharmaceuticals Inc   37.58 %
Vertex Pharmaceuticals Inc  36.81 %
Strongbridge Biopharma plc  34.65 %
Harrow Inc   32.26 %
Arrowhead Pharmaceuticals Inc   31.44 %
Align Technology inc   30.40 %
Lifevantage Corp  29.12 %
Corcept Therapeutics Inc  29.06 %

Date modified: 2026-09-08T15:09:44+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.